India to United States: Omeprazole Export Trade Route
India has recorded 3,102 verified shipments of Omeprazole exported to United States, representing a combined trade value of $188.7M USD. This corridor is served by 34 active Indian exporters, with an average shipment value of $60.8K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 28% of total export value with 176 shipments worth $52.7M USD. On the buying side, CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest importer in United States with $42.4M USD in purchases. The top 3 suppliers — CIPLA LIMITED, GLENMARK PHARMACEUTICALS LIMITED, DR.REDDY'S LABORATORIES LTD — together control 58% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Omeprazole corridor is one of India's established pharmaceutical export routes, with 3,102 shipments documented worth a combined $188.7M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 28% of all export value, reflecting the consolidated nature of India's omeprazole manufacturing sector.
Across 34 active suppliers, the average shipment value stands at $60.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with omeprazole's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 26.6%, placing it at rank #13 among India's top omeprazole export destinations globally.
On the import side, key buyers of Indian omeprazole in United States include CIPLA USA INC UPS SUPPLY CHAIN SOLU, EVERSANA LIFE SCIENCE SERVICES, GLENMARK PHARMACEUTICALS INC., USA and 175 others. CIPLA USA INC UPS SUPPLY CHAIN SOLU is the single largest importer with 135 shipments valued at $42.4M USD.
Route Characteristics
- Average transit30 days
- Peak seasonQ3
- Primary modeSea freight
- Top portHYDERABAD ICD
Market Position
- Global rank#13
- Annual growth+26.6%
- Demand growth+24.2%
- Regulatory ease83/100
Top 10 Indian Omeprazole Exporters to United States
Showing top 10 of 34 Indian suppliers exporting Omeprazole to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED Avg $299.3K per shipment | 176 | $52.7M | 27.9% |
| 2 | GLENMARK PHARMACEUTICALS LIMITED Avg $43.7K per shipment | 705 | $30.8M | 16.3% |
| 3 | DR.REDDY'S LABORATORIES LTD Avg $37.2K per shipment | 711 | $26.5M | 14.0% |
| 4 | ZYDUS LIFESCIENCES LIMITED Avg $50.7K per shipment | 278 | $14.1M | 7.5% |
| 5 | DR REDDYS LABORATORIES LIMITED Avg $61.4K per shipment | 177 | $10.9M | 5.8% |
| 6 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $43.9K per shipment | 167 | $7.3M | 3.9% |
| 7 | BIOCON PHARMA LIMITED Avg $48.1K per shipment | 140 | $6.7M | 3.6% |
| 8 | DR REDDY S LABORATORIES LIMITED Avg $99.7K per shipment | 67 | $6.7M | 3.5% |
| 9 | ANNORA PHARMA PRIVATE LIMITED Avg $36.8K per shipment | 151 | $5.6M | 2.9% |
| 10 | MYLAN LABORATORIES LIMITED Avg $140.8K per shipment | 29 | $4.1M | 2.2% |
This table shows the top 10 of 34 Indian companies exporting omeprazole to United States, ranked by total trade value. The listed exporters are: CIPLA LIMITED, GLENMARK PHARMACEUTICALS LIMITED, DR.REDDY'S LABORATORIES LTD, ZYDUS LIFESCIENCES LIMITED, DR REDDYS LABORATORIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, BIOCON PHARMA LIMITED, DR REDDY S LABORATORIES LIMITED, ANNORA PHARMA PRIVATE LIMITED, MYLAN LABORATORIES LIMITED. CIPLA LIMITED is the dominant supplier with 176 shipments worth $52.7M USD, giving it a 28% market share. The top 3 suppliers together account for 58% of the total trade value on this route.
Showing top 10 of 34 total Indian exporters on the India to United States Omeprazole export route.
Top 10 Omeprazole Importers in United States
Showing top 10 of 178 known buyers in United States receiving Omeprazole shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian omeprazole in United States include CIPLA USA INC UPS SUPPLY CHAIN SOLU, EVERSANA LIFE SCIENCE SERVICES, GLENMARK PHARMACEUTICALS INC., USA, DR REDDYS LABORATORIES INC, GLENMARK PHARMACEUTICALS INC USA, among 178 total buyers. The largest importer is CIPLA USA INC UPS SUPPLY CHAIN SOLU, accounting for $42.4M USD across 135 shipments — representing 22% of all omeprazole imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA USA INC UPS SUPPLY CHAIN SOLU | 135 | $42.4M | 22.5% |
| 2 | EVERSANA LIFE SCIENCE SERVICES | 310 | $18.9M | 10.0% |
| 3 | GLENMARK PHARMACEUTICALS INC., USA | 308 | $14.6M | 7.7% |
| 4 | DR REDDYS LABORATORIES INC | 176 | $11.2M | 6.0% |
| 5 | GLENMARK PHARMACEUTICALS INC USA | 238 | $10.6M | 5.6% |
| 6 | CIPLA USA INC UPS SUPPLY CHAIN SOL | 38 | $10.0M | 5.3% |
| 7 | NORTHSTAR DISTRIBUTION CENTER 8912 | 242 | $7.6M | 4.0% |
| 8 | DR. REDDYS LABORATORIES, INC | 115 | $5.4M | 2.9% |
| 9 | BIOCON PHARMA INC | 110 | $5.2M | 2.7% |
| 10 | OHM LABORATORIES INC | 84 | $4.0M | 2.1% |
Showing top 10 of 178 Omeprazole importers in United States on this route.
Top 10 Omeprazole Formulations Imported by United States
Showing top 10 of 1,644 product formulations shipped on the India to United States Omeprazole route, ranked by trade value
United States imports a wide range of omeprazole formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEASE ORAL SUSPENSION 40MG NDC NO. 69097-529-34 ANDA NO. 211751 (INV.QTY.3240 — accounts for $7.1M USD across 2 shipments. There are 1,644 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEASE ORAL SUSPENSION 40MG NDC NO. 69097-529-34 ANDA NO. 211751 (INV.QTY.3240 | 2 | $7.1M | 3.8% |
| 2 | ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEASE ORAL SUSPENSION 40MG NDC NO. 69097-529-34 ANDA NO. 211751(INV.QTY.3216 | 1 | $6.8M | 3.6% |
| 3 | ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEASE ORAL SUSPENSION 10MG;NDC NO.:69097-527-34; ANDA NO.:211752PACK SIZE:30X3.2GM | 1 | $6.1M | 3.2% |
| 4 | ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEASE ORAL SUSPENSION 10MG;NDC NO.:69097-527-34;(PS:30X3.2GMX3252 PACK=97560 NOS) | 1 | $6.1M | 3.2% |
| 5 | OMEPRAZOLE DR CAP 40MG 1000 | 140 | $6.1M | 3.2% |
| 6 | OMEPRAZOLE DR CAP 20MG 1000 | 95 | $3.5M | 1.9% |
| 7 | ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEA | 14 | $3.0M | 1.6% |
| 8 | OMEPRAZOLE DR CAPS USP 40 MG 1 X 1000 | 49 | $2.9M | 1.6% |
| 9 | OMEPRAZOLE MAGNESIUM DELAYED RELEASE | 13 | $2.1M | 1.1% |
| 10 | ESOMEPRAZOLE MAGNESIUM CAPS | 42 | $1.9M | 1.0% |
Showing top 10 of 1,644 Omeprazole formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 80%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD ICD handles the highest volume with 516 shipments. Transit time averages 30 days by sea.
Market Dynamics
India's omeprazole exports to United States are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 176 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 34 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CIPLA LIMITED, GLENMARK PHARMACEUTICALS LIMITED, DR.REDDY'S LABORATORIES LTD — together account for 58% of total trade value on this route. The average shipment value of $60.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as esomeprazole magnesium for delayed release oral suspension 40mg ndc no. 69097-529-34 anda no. 211751(inv.qty.3216 and esomeprazole magnesium for delayed release oral suspension 10mg;ndc no.:69097-527-34; anda no.:211752pack size:30x3.2gm, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest importer with 135 shipments worth $42.4M USD — representing 22% of all omeprazole imports from India on this route. A total of 178 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $188.7M
- Avg. Shipment
- $60.8K
- Suppliers
- 34
- Buyers
- 178
- Transit (Sea)
- ~30 days
- Annual Growth
- +26.6%
Related Analysis
Reverse Direction
United States → India — Omeprazole (Import)Other Omeprazole Routes
Unlock the Full India to United States Omeprazole Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 3,102 shipments on this route.
Frequently Asked Questions — India to United States Omeprazole Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Omeprazole to United States?
The leading Indian exporters of Omeprazole to United States are CIPLA LIMITED, GLENMARK PHARMACEUTICALS LIMITED, DR.REDDY'S LABORATORIES LTD. CIPLA LIMITED holds the largest market share at approximately 28% of total trade value on this route.
Q What is the total value of Omeprazole exports from India to United States?
India exports Omeprazole to United States worth approximately $188.7M USD across 3,102 recorded shipments. The average value per shipment is $60.8K USD.
Q Which ports does India use to ship Omeprazole to United States?
The most active port of origin is HYDERABAD ICD with 516 shipments. Indian exporters primarily use sea freight for this route, with 80% of shipments going by sea and 26% by air.
Q How long does shipping take from India to United States for Omeprazole?
The average transit time for Omeprazole shipments from India to United States is approximately 30 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to United States Omeprazole trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 26.6% with demand growth tracking at 24.2%. The route is ranked #13 among India's top Omeprazole export destinations globally.
Q How many suppliers are active on the India to United States Omeprazole route?
There are currently 34 active Indian suppliers exporting Omeprazole to United States. The market is moderately concentrated with CIPLA LIMITED accounting for 28% of total shipment value.
Q Who are the main importers of Omeprazole from India in United States?
The leading importers of Indian Omeprazole in United States include CIPLA USA INC UPS SUPPLY CHAIN SOLU, EVERSANA LIFE SCIENCE SERVICES, GLENMARK PHARMACEUTICALS INC., USA, DR REDDYS LABORATORIES INC, GLENMARK PHARMACEUTICALS INC USA. CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest buyer with 135 shipments worth $42.4M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Omeprazole.
- 2.Supplier/Buyer Matching: 34 Indian exporters and 178 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 3,102 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,102 Verified Shipments
34 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists